QIU, YAO-LING,CAO, HUI,PENG, XIAOWEN,CHEN, ZHIGANG,OR, YAT, SUN
申请号：
EP12842339
公开号：
EP2768517A4
申请日:
2012.10.17
申请国别(地区):
EP
年份:
2015
代理人:
摘要：
The invention discloses compounds of formula (I), pharmaceutically acceptable salt, ester or pro-drugs: Q-G-A-L-BZW (I), inhibits the virus containing RNA, especially hepatitis C virus (HCV). Therefore, the compound of the present invention interferes the life cycle of hepatitis C virus and also can be used as antiviral agents. The invention further relates to the above-mentioned compounds that pharmaceutical compositions include the management for the patient to a HCV infection. The invention further relates to methods, and a HCV infection is handled in a main body by the pharmaceutical composition that management includes the compound of the present invention.
